Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Opus Genetics Announces FDA Clearance of IND Application for Gene Therapy Candidate OPGx-BEST1
-
Cuprina Reaffirms Commitment to Shareholders and Patients Following Recent Stock Market Activity
-
The Oncology Institute and Doctors Healthcare Plans Partner to Elevate Oncology Care Management in South Florida
-
Lotus Technology to Report Unaudited First Half 2025 Financial Results on August 29, 2025
-
Rezolve Ai Celebrates One Year Anniversary of Nasdaq Listing with Explosive Growth, $70M+ ARR, and Global Expansion
-
YY Group Launches AI-Powered Customer Service and Expands into AI Recruitment Platform
-
Catheter Precision Receives Approval for LockeT in the United Kingdom
-
Synergy CHC Corp. (NASDAQ: SNYR) Announces Nationwide EG America Rollout for FOCUSfactor® Focus + Energy
-
Treatment.com AI Inc. to Rebrand as Rocket Doctor AI Inc., Aligning Business with Evolving Product Portfolio and Market Strategy
-
Eos Energy Enterprises Appoints Industry Veteran John Mahaz as Chief Operating Officer to Drive Next Phase of Operational Growth in American-Made Energy Storage
-
Equus Announces Second Quarter Net Asset Value
-
Critical Metals Corp Reports Extremely High-Grade Drilling Results From its 2024 Program: 103 PPM Gallium & rare earth elements of 27.0% HREO & TREO Range 0.48% to 0.55% & Zirconium Oxide of 1.99% Fr
-
DeFi Development Corp. to Participate in the Lytham Partners 2025 Consumer & Technology Investor Summit on August 19, 2025
-
Ultragenyx Initiates Rolling Submission of Biologics License Application (BLA) to U.S. FDA for DTX401 AAV Gene Therapy for the Treatment of Glycogen Storage Disease Type Ia (GSDIa)
-
NewAmsterdam Announces Acceptance of Marketing Authorization Applications for Review by European Medicine Agency for Obicetrapib
-
Pelthos Therapeutics Reports Second Quarter 2025 Financial Results for Legacy Operations and Provides Business Update
-
Alpha Modus Agrees to Preferred Stock Exchange to Eliminate ~$41 Million in Mezzanine Equity, Strengthening Balance Sheet, and Fully Aligning Insider Interests
-
Real Career Mode FC Launches Fan-Driven Football Club Ownership Model
-
LIXTE Biotechnology Holdings Provides Corporate Update
-
Legend Biotech Appoints Carlos Santos as Chief Financial Officer
-
Nuvini Group Unveils New Leadership Incentive Plan, Underscoring Commitment to Shareholders
-
Optex Systems to Present at the 2025 Gateway Conference on September 4
-
Aditude Appoints Anthony Gonsalves as First Chief Revenue Officer
-
Hepsiburada Announces Ordinary General Assembly Meeting for Financial Year 2024
-
Schouw & Co. share buy-back programme, week 33 2025
-
STMicroelectronics Announces Status of Common Share Repurchase Program
-
JDE Peet’s share buyback periodic update August 18, 2025
-
Enlivex Announces Positive Topline Data From Multi-Country, Randomized, Controlled, Phase I/II Trial Evaluating Allocetra in Patients With Moderate-To-Severe Knee Osteoarthritis
-
Conversion of Senior Unsecured Convertible Debentures Due August 30, 2027
-
Alert for Long-Term Shareholders of Flywire Corporation (NASDAQ: FLYW); Ibotta, Inc. (NYSE: IBTA); iRobot Corporation (NASDAQ: IRBT); and SelectQuote, Inc. (NYSE: SLQT); Grabar Law Office is Investiga
-
Holding(s) in Company
-
ParaZero Receives Order from a Defense Entity for its Counter Drone Technology
-
Auction result of Treasury Bills - RIKV 25 1119 - RIKV 26 0318
-
Mattr Appoints New Director
-
180 Degree Capital Corp. and Mount Logan Capital Inc. Announce Revised Terms of Business Combination in Response to Constructive Conversations with Shareholders
-
Aptose Reports Early Data Demonstrating Tuspetinib Improves Standard of Care Treatment Across Diverse Populations of Newly Diagnosed AML in Phase 1/2 TUSCANY Trial
-
Promising Outcome From Collaboration With Dundee Sustainable Technologies
-
Plus Therapeutics Presents Positive ReSPECT-LM Clinical Trial Results of REYOBIQ™ in Leptomeningeal Metastases
-
PDD Holdings to Report Second Quarter 2025 Unaudited Financial Results on August 25, 2025
-
Theratechnologies Announces Filing of Special Meeting Materials and Receipt of Interim Order in Relation to its Acquisition by CB Biotechnology, an Affiliate of Future Pak
-
DallasNews Corporation Files Definitive Proxy Statement and Issues Letter to Shareholders
-
OneMedNet initiates new Subscription Revenue model in partnership with Circle CVI
-
Reunion Neuroscience Announces Positive Topline Results from RECONNECT Phase 2 Clinical Trial of RE104 for the Treatment of Postpartum Depression (PPD)
-
SL Green Realty Corp. Announces Common Stock Dividend
-
Allied Provides Development Update
-
Hisummer Launches Two Flameless Candle Warmer Lamps for Fall & Winter 2025 Décor and Gifting
-
Hisummer Launches Two Flameless Candle Warmer Lamps for Fall & Winter 2025 Décor and Gifting
-
Bitdeer Reports Unaudited Financial Results for the Second Quarter of 2025
-
Howard Hughes Holdings to Host Annual Shareholder Meeting on September 30 at 9:00 a.m. at The Pershing Square Signature Center in New York City
-
Coppernico Advances New Copper-Gold Alteration Systems at Sombrero
